The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review
ReviewHumans
- Design
- Review
- Subjects
- Qualitative systematic review
- Dose used in the study
- Not applicable
- Duration
- Not applicable
- What was measured
- Trials of palmitoylethanolamide relevant to palliative care: pain, depression, Parkinson's disease, stroke, autism; adverse effects and interactions
What the authors reported
A significant number of trials show pain relief, with weaker evidence for non-pain symptoms, no reported drug interactions and few adverse effects; the authors note little is known about pharmacokinetics.
Limits of this study
Qualitative, so no pooled estimate. Written by an independent US palliative care group. Its comment that no interactions are reported reflects absence of study, not evidence of safety; see the safety page.
Source
PubMed 31113223 · doi:10.1177/1049909119850807
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.